#linkedin is a plague....
Explore tagged Tumblr posts
Text

go fuck yourself, man
2 notes
·
View notes
Text

The last week’s been absolutely crazy, and the next month’ll keep getting crazy, but right now I’m just glad to be home and bundled up with Sunny at my side ^_^
#cheeky barks#I was at the Game Developers Conference last week! it was super scary and draining but super fun also#I left Sunny at home bc I was scared of something happening to him at a networking party or getting contaminated w Conference Plague#and while I had Wee Hen I missed him a lot :( the first thing I did when I got home was cuddle him tightly and get some sleep#maybe if I go to GDC again in the future and feel safer abt everything I can bring him with :)#I’m graduating my undergrad in a little over a month and only got to go from a scholarship so it may be a while b4 I can afford it again#but we’ll see :)#also I got to connect w a game dev I’ve liked for a LONG time on LinkedIn which was cool! she’s no Toby Fox but I love her games a lot#okay I’m gonna stop rambling abt my trip now. Ty for reading and looking at Sunny#webkinz#dog#plushblr#plush#actually autistic#safeplush#webkinz signature#my plush: sunny#comfort plush#emotional support plush
10 notes
·
View notes
Text
soooooooooo the punk rock mba was just a huge poser and grifter. cool cool that's not depressing or anything
#txt#'it's just a youtuber' yes ik that#but when you follow someone bc you think they're passionate about smth then they turn around and go 'actually i was doing this for money'#that shit is such a bummer!#and he approached it in such a shitty way too#like he wants to be a LINKEDIN INFLUENCER?????#god what a plague those are
0 notes
Text
Hey LinkedIn, c'mere. No, closer. Squeeze in real close, I want to tell you something important.
You see that little AI tool you're offering as help for building my profile?
I would rather die.
Thanks! Shoo.
0 notes
Text
job hunting has drained my brain of anything else because I just forgot I was supposed to hang out with my friends, what’s the point of living anymore
0 notes
Text
I want to address a plague across the world of copy. I see it everywhere: first drafts posted to subreddits and forums asking for critique, landing pages for copywriting courses, and especially on LinkedIn. Once you see it, you can’t unsee it. You may already know what I mean. This. This self-important, faux-inspirational shortcut to Good Writing™. This Descending Copy Ladder to Hell. No one on Earth naturally writes like this, and they certainly don’t like reading it. Except for one group of people. Copywriters. And not just copywriters. Copywriters writing for other copywriters. We need to talk about it.
My latest for Inkspiller talks about the most annoying writing on LinkedIn, why it's bad, and why you should push yourself to grow beyond it.
Read it here: The Descending Copy Ladder to Hell
63 notes
·
View notes
Note
mat and mama b first breakup + 23. "Don't say that." + 55. "We tried, but it just didn't work out." 💔
-linkedin anon
Having to work together after a breakup was always going to be hard.
Even harder for her, considering all of his friends were her friends too and they obviously were going to pick Mat’s side.
They were on the road in Chicago and the team was out at a bar. She didn’t want to go but they’d invited her and her medical partner wanted to go so she joined in.
Her and Mat avoided each other like the plague, looking away and making sure to sit far enough apart.
That was until she was on route to the bathroom and overheard Ollie talking to Mat.
“Hey man, what’s up with you and Y/N? I thought you liked her big time”
Mat sighed, sipping his beer “Yeah man, I don’t know we tried, but it just didn’t work out”
“You always let the good ones away” Ollie joked, shoving his teammate playfully.
“Hey this was all her man, she’s too difficult-“
“Oh I’m difficult?” Mat flinched at the sound of her voice.
“Y/N…”
“You’re a fucking coward Mat! You’re gonna throw me under the bus and paint me out to be some obsessed little fan girl? Fuck you!”
“Babe, fuck, Y/N wait!” She called out for her as she left the building. He took off after her, chasing her out the door
“Would you wait!”
She spun around to him, tears soaking her face “I hate you!”
“Don’t say that” he mumbled, attempting to pull her into him.
“I hate you Mat and I wish, I wish I’d never fallen in love with you”
The air got caught in his throat “You love me?”
“Not anymore”
24 notes
·
View notes
Text
Im starting to hate that linkedin ai concept artist post because i dont think believing in any sort of skill heirarchy (low skill jobs being valued less than high skill jobs) actually helps anyone and of course a lot of AI discourse is plagued by people who are essentially like class un-conscious luddites who can't percieve the world beyond their own fog
6 notes
·
View notes
Text

🤔 … something to think about, right? The irony of life!! — all I’m gonna say about the ‘attempt’!!
By: LaillaB, founder ‘Reclaim the Narrative’, from LinkedIn…
“The stark contrast between the near-miss experienced by convicted former US President Trump in Pennsylvania and the tragic fate of Hind Rajab in Gaza serves as an abhorrent illustration of the deep-rooted inequalities and injustices that plague our society.
On one hand, we see a powerful and privileged individual who narrowly escapes harm, highlighting the value and protection afforded to those in positions of authority.
The mere graze of a bullet on the ear of a world leader sparks international attention and concern, demonstrating the significance placed on the lives of the elite and influential.
On the other hand, we witness the brutal and senseless killing of 6 year old Hind Rajab, a victim of systemic violence perpetuated by the Israeli occupation.
The investigation found that the car in which Rajab was killed had been hit with 355 bullets, conducted by Forensic Architecture, Al Jazeera's Fault Lines and the NGO Earshot.
Forensic Architecture said that the gun used for this attack was "firing at a range of 750–900 rounds p/min", and that this range exceeds that of the AK-type assault rifle that is commonly attributed to Hamas.
"This range of rounds per minute is consistent with Israeli army-issued weaponry such as the M4 assault rifle or the FN MAG machine gun on a Merkava tank," the investigation said.
Her life, like so many Palestinians in the Gaza concentration camp, was tragically cut short, with little to no outcry or accountability for her untimely death.
The swift identification of the suspect in the shooting incident within hours, as Thomas Matthew Crooks also demonstrates the disparities in how justice is served and accountability is upheld, compared to that of a child, Rajab.
The juxtaposition of these two events serves as a cruel reminder of the disparities in power, privilege, and the value placed on human life.
Inna lillahi wa inna ilayhi raji’un 🕊
#reclaimthenarrative — 🍉🕊️ — #FreePalestine … @hrexach
#dr rex equality news information education#graphic source#graphic#graphics#hortyrex ©#horty#quote#it is what it is#republican hypocrisy#hind rajab#palestine#donald trump#staged#israel#irony
5 notes
·
View notes
Text
youtube
How Sunny Turned Uncertainty Into His Superpower
🌟 Sunny’s Story: Passion Over Academics
In 2013, Sunny made a decision that would change the course of his life—he stopped focusing on getting straight A’s. In a world where academic achievement is often seen as the only path to success, Sunny chose a different route: he followed his passion. 🧑🎓
"Everyone thought I was crazy," he shares in his interview on Business Story of the Week. But Sunny knew that his passion for leadership and social entrepreneurship would lead him down a unique and rewarding path.
His decision paid off in more ways than one. By focusing on what he loved, Sunny developed a deep understanding of leadership and public speaking, which would later become the foundation of his success.
Public Speaking and the Power of Social Skills
Sunny’s love for public speaking came from an early interest in connecting with people. His parents encouraged him to socialize, reinforcing the importance of communication. This confidence carried him through high school and beyond, turning him into a charismatic and effective speaker. 🎤
"Social skills are everything," he says. And it’s true. Sunny’s ability to engage with people helped him excel in both teaching and entrepreneurship.
Building an Unscalable Business
In 2019, Sunny tackled a problem that had been plaguing him for years: maintaining discipline. Instead of struggling alone, he created an accountability group that allowed him and others to support each other in building healthy habits.
For $20 a month, participants joined Sunny on calls where they discussed their progress. This "unscalable" business wasn’t about making millions—it was about solving a real problem in his life. And guess what? It worked! 💪
The Class That Broke All the Rules
By 2022, Sunny had the chance to create a university class that defied all expectations. With no tests, no homework, and no lectures, the course focused on helping students build real businesses from the ground up.
Students loved it! This hands-on approach gave them the tools they needed to succeed in entrepreneurship. "You can’t learn business from a textbook," Sunny says. "You have to experience it." 📚
Leaning Into Who He Is
In 2023, Sunny fully embraced his authentic self, stepping away from the corporate world and following his passion. His most unique project to date? Hosting dinners with strangers from LinkedIn!
"I wanted to connect with new people in a meaningful way," Sunny explains. This simple yet bold move is just one example of how he continues to embrace uncertainty and forge his own path.
The Takeaway
Sunny’s story teaches us that the road to success doesn’t have to be traditional. By embracing uncertainty and staying true to who you are, you can achieve success in ways you never imagined. So, what’s stopping you? Take that leap today! 🌈 #Entrepreneurship #BusinessJourney #PublicSpeaking #EmbraceUncertainty
2 notes
·
View notes
Text
Decisions by CVS and Optum Panicked Thousands of Their Sickest Patients
Arthur Allen
NEW YORK — The fear started when a few patients saw their nurses and dietitians posting job searches on LinkedIn.
Word spread to Facebook groups, and patients started calling Coram CVS, a major U.S. supplier of the compounded IV nutrients on which they rely for survival. To their dismay, CVS Health confirmed the rumors on June 1: It was closing 36 of the 71 branches of its Coram home infusion business and laying off about 2,000 nurses, dietitians, pharmacists, and other employees.
Many of the patients left in the lurch have life-threatening digestive disorders that render them unable to eat or drink. They depend on parenteral nutrition, or PN — in which amino acids, sugars, fats, vitamins, and electrolytes are pumped, in most cases, through a specialized catheter directly into a large vein near the heart.
The day after CVS’ move, another big supplier, Optum Rx, announced its own consolidation. Suddenly, thousands would be without their highly complex, shortage-plagued, essential drugs and nutrients.
“With this kind of disruption, patients can’t get through on the phones. They panic,” said Cynthia Reddick, a senior nutritionist who was let go in the CVS restructuring.
“It was very difficult. Many emails, many phone calls, acting as a liaison between my doctor and the company,” said Elizabeth Fisher Smith, a 32-year-old public health instructor in New York City, whose Coram branch closed. A rare medical disorder has forced her to rely on PN for survival since 2017. “In the end, I got my supplies, but it added to my mental burden. And I’m someone who has worked in health care nearly my entire adult life.”
CVS had abandoned most of its less lucrative market in home parenteral nutrition, or HPN, and “acute care” drugs like IV antibiotics. Instead, it would focus on high-dollar, specialty intravenous medications like Remicade, which is used for arthritis and other autoimmune conditions.
Home and outpatient infusions are a growing business in the United States, as new drugs for chronic illness enable patients, health care providers, and insurers to bypass in-person treatment. Even the wellness industry is cashing in, with spa storefronts and home hydration services.
But while reimbursement for expensive new drugs has drawn the interest of big corporations and private equity, the industry is strained by a lack of nurses and pharmacists. And the less profitable parts of the business — as well as the vulnerable patients they serve — are at serious risk.
This includes the 30,000-plus Americans who rely for survival on parenteral nutrition, which has 72 ingredients. Among those patients are premature infants and post-surgery patients with digestive problems, and people with short or damaged bowels, often the result of genetic defects.
While some specialty infusion drugs are billed through pharmacy benefit managers that typically pay suppliers in a few weeks, medical plans that cover HPN, IV antibiotics, and some other infusion drugs can take 90 days to pay, said Dan Manchise, president of Mann Medical Consultants, a home care consulting company.
In the 2010s, CVS bought Coram, and Optum bought up smaller home infusion companies, both with the hope that consolidation and scale would offer more negotiating power with insurers and manufacturers, leading to a more stable market. But the level of patient care required was too high for them to make money, industry officials said.
“With the margins seen in the industry,” Manchise said, “if you’ve taken on expensive patients and you don’t get paid, you’re dead.”
In September, CVS announced its purchase of Signify Health, a high-tech company that sends out home health workers to evaluate billing rates for “high-priority” Medicare Advantage patients, according to an analyst’s report. In other words, as CVS shed one group of patients whose care yields low margins, it was spending $8 billion to seek more profitable ones.
CVS “pivots when necessary,” spokesperson Mike DeAngelis told KHN. “We decided to focus more resources on patients who receive infusion services for specialty medications” that “continue to see sustained growth.” Optum declined to discuss its move, but a spokesperson said the company was “steadfastly committed to serving the needs” of more than 2,000 HPN patients.
DeAngelis said CVS worked with its HPN patients to “seamlessly transition their care” to new companies.
However, several Coram patients interviewed about the transition indicated it was hardly smooth. Other HPN businesses were strained by the new demand for services, and frightening disruptions occurred.
Smith had to convince her new supplier that she still needed two IV pumps — one for HPN, the other for hydration. Without two, she’d rely partly on “gravity” infusion, in which the IV bag hangs from a pole that must move with the patient, making it impossible for her to keep her job.
“They just blatantly told her they weren’t giving her a pump because it was more expensive, she didn’t need it, and that’s why Coram went out of business,” Smith said.
Many patients who were hospitalized at the time of the switch — several inpatient stays a year are not unusual for HPN patients — had to remain in the hospital until they could find new suppliers. Such hospitalizations typically cost at least $3,000 a day.
“The biggest problem was getting people out of the hospital until other companies had ramped up,” said Dr. David Seres, a professor of medicine at the Institute of Human Nutrition at Columbia University Medical Center. Even over a few days, he said, “there was a lot of emotional hardship and fear over losing long-term relationships.”
To address HPN patients’ nutritional needs, a team of physicians, nurses, and dietitians must work with their supplier, Seres said. The companies conduct weekly bloodwork and adjust the contents of the HPN bags, all under sterile conditions because these patients are at risk of blood infections, which can be grave.
As for Coram, “it’s pretty obvious they had to trim down business that was not making money,” Reddick said, adding that it was noteworthy both Coram and Optum Rx “pivoted the same way to focus on higher-dollar, higher-reimbursement, high-margin populations.”
“I get it, from the business perspective,” Smith said. “At the same time, they left a lot of patients in a not great situation.”
***
Smith shares a postage-stamp Queens apartment with her husband, Matt; his enormous flight simulator (he’s an amateur pilot); cabinets and fridges full of medical supplies; and two large, friendly dogs, Caspian and Gretl. On a recent morning, she went about her routine: detaching the bag of milky IV fluid that had pumped all night through a central line implanted in her chest, flushing the line with saline, injecting medications into another saline bag, and then hooking it through a paperback-sized pump into her central line.
Smith has a connective tissue disorder called Ehlers-Danlos syndrome, which can cause many health problems. As a child, Smith had frequent issues such as a torn Achilles tendon and shoulder dislocations. In her 20s, while working as an EMT, she developed severe gut blockages and became progressively less able to digest food. In 2017, she went on HPN and takes nothing by mouth except for an occasional sip of liquid or bite of soft food, in hopes of preventing the total atrophy of her intestines. HPN enabled her to commute to George Washington University in Washington, D.C., where in 2020 she completed a master’s in public health.
On days when she teaches at LaGuardia Community College — she had 35 students this semester — Smith is up at 6 a.m. to tend to her medical care, leaves the house at 9:15 for class, comes home in the afternoon for a bag of IV hydration, then returns for a late afternoon or evening class. In the evening she gets more hydration, then hooks up the HPN bag for the night. On rare occasions she skips the HPN, “but then I regret it,” she said. The next day she’ll have headaches and feel dizzy, sometimes losing her train of thought in class.
Smith describes a “love-hate relationship” with HPN. She hates being dependent on it, the sour smell of the stuff when it spills, and the mountains of unrecyclable garbage from the 120 pounds of supplies couriered to her apartment weekly. She worries about blood clots and infections. She finds the smell of food disconcerting; Matt tries not to cook when she’s home. Other HPN patients speak of sudden cravings for pasta or Frosted Mini-Wheats.
Yet HPN “has given me my life back,” Smith said.
She is a zealous self-caretaker, but some dangers are beyond her control. IV feeding over time is associated with liver damage. The assemblage of HPN bags by compounding pharmacists is risky. If the ingredients aren’t mixed in the right order, they can crystallize and kill a patient, said Seres, Smith’s doctor.
He and other doctors would like to transition patients to food, but this isn’t always possible. Some eventually seek drastic treatments such as bowel lengthening or even transplants of the entire digestive tract.
“When they run out of options, they could die,” said Dr. Ryan Hurt, a Mayo Clinic physician and president of the American Society for Parenteral and Enteral Nutrition.
***
And then there are the shortages.
In 2017, Hurricane Maria crippled dozens of labs and factories making IV components in Puerto Rico; next came the covid-19 emergency, which shifted vital supplies to gravely ill hospital patients.
Prices for vital HPN ingredients can fluctuate unpredictably as companies making them come and go. For example, in recent years the cost of the sodium acetate used as an electrolyte in a bag of HPN ballooned from $2 to $25, then briefly to $300, said Michael Rigas, a co-founder of the home infusion pharmacy KabaFusion.
“There may be 50 different companies involved in producing everything in an HPN bag,” Rigas said. “They’re all doing their own thing — expanding, contracting, looking for ways to make money.” This leaves patients struggling to deal with various shortages from saline and IV bags to special tubing and vitamins.
“In the last five years I’ve seen more things out of stock or on shortage than the previous 35 years combined,” said Rigas.
The sudden retrenchment of CVS and Optum Rx made things worse. Another, infuriating source of worry: the steady rise of IV spas and concierge services, staffed by moonlighting or burned-out hospital nurses, offering IV vitamins and hydration to well-off people who enjoy the rush of infusions to relieve symptoms of a cold, morning sickness, a hangover, or just a case of the blahs.
In January, infusion professionals urged FDA Commissioner Robert Califf to examine spa and concierge services’ use of IV products as an “emerging contributing factor” to shortages.
The FDA, however, has little authority over IV spas. The Federal Trade Commission has cracked down on some spa operations — for unsubstantiated health claims rather than resource misuse.
Bracha Banayan’s concierge service, called IVDRIPS, started in 2017 in New York City and now employs 90 people, including 60 registered nurses, in four states, she said. They visit about 5,000 patrons each year, providing IV hydration and vitamins in sessions of an hour or two for up to $600 a visit. The goal is “to hydrate and be healthy” with a “boost that makes us feel better,” Banayan said.
Although experts don’t recommend IV hydration outside of medical settings, the market has exploded, Banayan said: “Every med spa is like, ‘We want to bring in IV services.’ Every single paramedic I know is opening an IV center.”
Matt Smith, Elizabeth’s husband, isn’t surprised. Educated as a lawyer, he is a paramedic who trains others at Columbia University Irving Medical Center. “You give someone a choice of go up to some rich person’s apartment and start an IV on them, or carry a 500-pound person living in squalor down from their apartment,” he said. “There’s one that’s going to be very hard on your body and one very easy on your body.”
The very existence of IV spa companies can feel like an insult.
“These people are using resources that are literally a matter of life or death to us,” Elizabeth Smith said.
Shortages in HPN supplies have caused serious health problems including organ failure, severe blisters, rashes, and brain damage.
For five months last year, Rylee Cornwell, 18 and living in Spokane, Washington, could rarely procure lipids for her HPN treatment. She grew dizzy or fainted when she tried to stand, so she mostly slept. Eventually she moved to Phoenix, where the Mayo Clinic has many Ehlers-Danlos patients and supplies are easier to access.
Mike Sherels was a University of Minnesota Gophers football coach when an allergic reaction caused him to lose most of his intestines. At times he’s had to rely on an ethanol solution that damages the ports on his central line, a potentially deadly problem “since you can only have so many central access sites put into your body during your life,” he said.
When Faith Johnson, a 22-year-old Las Vegas student, was unable to get IV multivitamins, she tried crushing vitamin pills and swallowing the powder, but couldn’t keep the substance down and became malnourished. She has been hospitalized five times this past year.
Dread stalks Matt Smith, who daily fears that Elizabeth will call to say she has a headache, which could mean a minor allergic or viral issue — or a bloodstream infection that will land her in the hospital.
Even more worrying, he said: “What happens if all these companies stop doing it? What is the alternative? I don’t know what the economics of HPN are. All I know is the stuff either comes or it doesn’t.”
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.
USE OUR CONTENT
This story can be republished for free (details).
Read more here https://angelino.news
3 notes
·
View notes
Text
Decisions by CVS and Optum Panicked Thousands of Their Sickest Patients
Arthur Allen
NEW YORK — The fear started when a few patients saw their nurses and dietitians posting job searches on LinkedIn.
Word spread to Facebook groups, and patients started calling Coram CVS, a major U.S. supplier of the compounded IV nutrients on which they rely for survival. To their dismay, CVS Health confirmed the rumors on June 1: It was closing 36 of the 71 branches of its Coram home infusion business and laying off about 2,000 nurses, dietitians, pharmacists, and other employees.
Many of the patients left in the lurch have life-threatening digestive disorders that render them unable to eat or drink. They depend on parenteral nutrition, or PN — in which amino acids, sugars, fats, vitamins, and electrolytes are pumped, in most cases, through a specialized catheter directly into a large vein near the heart.
The day after CVS’ move, another big supplier, Optum Rx, announced its own consolidation. Suddenly, thousands would be without their highly complex, shortage-plagued, essential drugs and nutrients.
“With this kind of disruption, patients can’t get through on the phones. They panic,” said Cynthia Reddick, a senior nutritionist who was let go in the CVS restructuring.
“It was very difficult. Many emails, many phone calls, acting as a liaison between my doctor and the company,” said Elizabeth Fisher Smith, a 32-year-old public health instructor in New York City, whose Coram branch closed. A rare medical disorder has forced her to rely on PN for survival since 2017. “In the end, I got my supplies, but it added to my mental burden. And I’m someone who has worked in health care nearly my entire adult life.”
CVS had abandoned most of its less lucrative market in home parenteral nutrition, or HPN, and “acute care” drugs like IV antibiotics. Instead, it would focus on high-dollar, specialty intravenous medications like Remicade, which is used for arthritis and other autoimmune conditions.
Home and outpatient infusions are a growing business in the United States, as new drugs for chronic illness enable patients, health care providers, and insurers to bypass in-person treatment. Even the wellness industry is cashing in, with spa storefronts and home hydration services.
But while reimbursement for expensive new drugs has drawn the interest of big corporations and private equity, the industry is strained by a lack of nurses and pharmacists. And the less profitable parts of the business — as well as the vulnerable patients they serve — are at serious risk.
This includes the 30,000-plus Americans who rely for survival on parenteral nutrition, which has 72 ingredients. Among those patients are premature infants and post-surgery patients with digestive problems, and people with short or damaged bowels, often the result of genetic defects.
While some specialty infusion drugs are billed through pharmacy benefit managers that typically pay suppliers in a few weeks, medical plans that cover HPN, IV antibiotics, and some other infusion drugs can take 90 days to pay, said Dan Manchise, president of Mann Medical Consultants, a home care consulting company.
In the 2010s, CVS bought Coram, and Optum bought up smaller home infusion companies, both with the hope that consolidation and scale would offer more negotiating power with insurers and manufacturers, leading to a more stable market. But the level of patient care required was too high for them to make money, industry officials said.
“With the margins seen in the industry,” Manchise said, “if you’ve taken on expensive patients and you don’t get paid, you’re dead.”
In September, CVS announced its purchase of Signify Health, a high-tech company that sends out home health workers to evaluate billing rates for “high-priority” Medicare Advantage patients, according to an analyst’s report. In other words, as CVS shed one group of patients whose care yields low margins, it was spending $8 billion to seek more profitable ones.
CVS “pivots when necessary,” spokesperson Mike DeAngelis told KHN. “We decided to focus more resources on patients who receive infusion services for specialty medications” that “continue to see sustained growth.” Optum declined to discuss its move, but a spokesperson said the company was “steadfastly committed to serving the needs” of more than 2,000 HPN patients.
DeAngelis said CVS worked with its HPN patients to “seamlessly transition their care” to new companies.
However, several Coram patients interviewed about the transition indicated it was hardly smooth. Other HPN businesses were strained by the new demand for services, and frightening disruptions occurred.
Smith had to convince her new supplier that she still needed two IV pumps — one for HPN, the other for hydration. Without two, she’d rely partly on “gravity” infusion, in which the IV bag hangs from a pole that must move with the patient, making it impossible for her to keep her job.
“They just blatantly told her they weren’t giving her a pump because it was more expensive, she didn’t need it, and that’s why Coram went out of business,” Smith said.
Many patients who were hospitalized at the time of the switch — several inpatient stays a year are not unusual for HPN patients — had to remain in the hospital until they could find new suppliers. Such hospitalizations typically cost at least $3,000 a day.
“The biggest problem was getting people out of the hospital until other companies had ramped up,” said Dr. David Seres, a professor of medicine at the Institute of Human Nutrition at Columbia University Medical Center. Even over a few days, he said, “there was a lot of emotional hardship and fear over losing long-term relationships.”
To address HPN patients’ nutritional needs, a team of physicians, nurses, and dietitians must work with their supplier, Seres said. The companies conduct weekly bloodwork and adjust the contents of the HPN bags, all under sterile conditions because these patients are at risk of blood infections, which can be grave.
As for Coram, “it’s pretty obvious they had to trim down business that was not making money,” Reddick said, adding that it was noteworthy both Coram and Optum Rx “pivoted the same way to focus on higher-dollar, higher-reimbursement, high-margin populations.”
“I get it, from the business perspective,” Smith said. “At the same time, they left a lot of patients in a not great situation.”
***
Smith shares a postage-stamp Queens apartment with her husband, Matt; his enormous flight simulator (he’s an amateur pilot); cabinets and fridges full of medical supplies; and two large, friendly dogs, Caspian and Gretl. On a recent morning, she went about her routine: detaching the bag of milky IV fluid that had pumped all night through a central line implanted in her chest, flushing the line with saline, injecting medications into another saline bag, and then hooking it through a paperback-sized pump into her central line.
Smith has a connective tissue disorder called Ehlers-Danlos syndrome, which can cause many health problems. As a child, Smith had frequent issues such as a torn Achilles tendon and shoulder dislocations. In her 20s, while working as an EMT, she developed severe gut blockages and became progressively less able to digest food. In 2017, she went on HPN and takes nothing by mouth except for an occasional sip of liquid or bite of soft food, in hopes of preventing the total atrophy of her intestines. HPN enabled her to commute to George Washington University in Washington, D.C., where in 2020 she completed a master’s in public health.
On days when she teaches at LaGuardia Community College — she had 35 students this semester — Smith is up at 6 a.m. to tend to her medical care, leaves the house at 9:15 for class, comes home in the afternoon for a bag of IV hydration, then returns for a late afternoon or evening class. In the evening she gets more hydration, then hooks up the HPN bag for the night. On rare occasions she skips the HPN, “but then I regret it,” she said. The next day she’ll have headaches and feel dizzy, sometimes losing her train of thought in class.
Smith describes a “love-hate relationship” with HPN. She hates being dependent on it, the sour smell of the stuff when it spills, and the mountains of unrecyclable garbage from the 120 pounds of supplies couriered to her apartment weekly. She worries about blood clots and infections. She finds the smell of food disconcerting; Matt tries not to cook when she’s home. Other HPN patients speak of sudden cravings for pasta or Frosted Mini-Wheats.
Yet HPN “has given me my life back,” Smith said.
She is a zealous self-caretaker, but some dangers are beyond her control. IV feeding over time is associated with liver damage. The assemblage of HPN bags by compounding pharmacists is risky. If the ingredients aren’t mixed in the right order, they can crystallize and kill a patient, said Seres, Smith’s doctor.
He and other doctors would like to transition patients to food, but this isn’t always possible. Some eventually seek drastic treatments such as bowel lengthening or even transplants of the entire digestive tract.
“When they run out of options, they could die,” said Dr. Ryan Hurt, a Mayo Clinic physician and president of the American Society for Parenteral and Enteral Nutrition.
***
And then there are the shortages.
In 2017, Hurricane Maria crippled dozens of labs and factories making IV components in Puerto Rico; next came the covid-19 emergency, which shifted vital supplies to gravely ill hospital patients.
Prices for vital HPN ingredients can fluctuate unpredictably as companies making them come and go. For example, in recent years the cost of the sodium acetate used as an electrolyte in a bag of HPN ballooned from $2 to $25, then briefly to $300, said Michael Rigas, a co-founder of the home infusion pharmacy KabaFusion.
“There may be 50 different companies involved in producing everything in an HPN bag,” Rigas said. “They’re all doing their own thing — expanding, contracting, looking for ways to make money.” This leaves patients struggling to deal with various shortages from saline and IV bags to special tubing and vitamins.
“In the last five years I’ve seen more things out of stock or on shortage than the previous 35 years combined,” said Rigas.
The sudden retrenchment of CVS and Optum Rx made things worse. Another, infuriating source of worry: the steady rise of IV spas and concierge services, staffed by moonlighting or burned-out hospital nurses, offering IV vitamins and hydration to well-off people who enjoy the rush of infusions to relieve symptoms of a cold, morning sickness, a hangover, or just a case of the blahs.
In January, infusion professionals urged FDA Commissioner Robert Califf to examine spa and concierge services’ use of IV products as an “emerging contributing factor” to shortages.
The FDA, however, has little authority over IV spas. The Federal Trade Commission has cracked down on some spa operations — for unsubstantiated health claims rather than resource misuse.
Bracha Banayan’s concierge service, called IVDRIPS, started in 2017 in New York City and now employs 90 people, including 60 registered nurses, in four states, she said. They visit about 5,000 patrons each year, providing IV hydration and vitamins in sessions of an hour or two for up to $600 a visit. The goal is “to hydrate and be healthy” with a “boost that makes us feel better,” Banayan said.
Although experts don’t recommend IV hydration outside of medical settings, the market has exploded, Banayan said: “Every med spa is like, ‘We want to bring in IV services.’ Every single paramedic I know is opening an IV center.”
Matt Smith, Elizabeth’s husband, isn’t surprised. Educated as a lawyer, he is a paramedic who trains others at Columbia University Irving Medical Center. “You give someone a choice of go up to some rich person’s apartment and start an IV on them, or carry a 500-pound person living in squalor down from their apartment,” he said. “There’s one that’s going to be very hard on your body and one very easy on your body.”
The very existence of IV spa companies can feel like an insult.
“These people are using resources that are literally a matter of life or death to us,” Elizabeth Smith said.
Shortages in HPN supplies have caused serious health problems including organ failure, severe blisters, rashes, and brain damage.
For five months last year, Rylee Cornwell, 18 and living in Spokane, Washington, could rarely procure lipids for her HPN treatment. She grew dizzy or fainted when she tried to stand, so she mostly slept. Eventually she moved to Phoenix, where the Mayo Clinic has many Ehlers-Danlos patients and supplies are easier to access.
Mike Sherels was a University of Minnesota Gophers football coach when an allergic reaction caused him to lose most of his intestines. At times he’s had to rely on an ethanol solution that damages the ports on his central line, a potentially deadly problem “since you can only have so many central access sites put into your body during your life,” he said.
When Faith Johnson, a 22-year-old Las Vegas student, was unable to get IV multivitamins, she tried crushing vitamin pills and swallowing the powder, but couldn’t keep the substance down and became malnourished. She has been hospitalized five times this past year.
Dread stalks Matt Smith, who daily fears that Elizabeth will call to say she has a headache, which could mean a minor allergic or viral issue — or a bloodstream infection that will land her in the hospital.
Even more worrying, he said: “What happens if all these companies stop doing it? What is the alternative? I don’t know what the economics of HPN are. All I know is the stuff either comes or it doesn’t.”
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.
USE OUR CONTENT
This story can be republished for free (details).
Read more here https://angelino.news
3 notes
·
View notes
Text
How Our Clients Used Automation to Grow Their Business Fast?

Neebify is an automation platform that empowers businesses to automate repetitive tasks and make processes seamless with high productivity. It has been successfully deployed by clients to scale their business quickly and take advantages on many levels.
1. Smoothened Lead Generation: Neebify automates the whole lead generation process in LinkedIn, right from the selection of the target audience to sending personalized invitations to them. This brings in continuous prospects of qualified leads, reducing time and effort toward the conversion of prospects to customers.
2. Enhanced Personalisation and Engagement: Neebify allows for personalized communication through the integration of data about customers using any CRM system, thus improving engagement and conversions.
3. Efficiency and Productivity: Neebify automates the mundane tasks of a professional resource so that resources can think over core strategies.
4. Data-Driven Smart Choices: With deep analyses of campaigns provided by Neebify, the company is in a position to make smart decisions by key metrics in response rates, growth of contacts, or conversion rates.
5. Smoothen Sales Management: Integration with CRM tools by Neebify will enable the smooth management of sales funnels.
A tangible example of how Neebify can grow a business is a B2B software development firm that was able to grow its business 200% in six months. It was plagued by problems common to several companies: dismal lead volume, poor sales processes, and low engagement rates.
Software Development Firm utilized Neebify to automate finding leads and sales outreach on LinkedIn. It allowed them to automate lead creation, personalized touches for most of them, organized sales pipeline management, and optimized campaigns based on data analysis. As they integrated Neebify with their CRM, it allowed the firm to automate the flow of the leads from LinkedIn into the CRM, saving themselves the headache of manually typing in so much data into the CRM.
Neebify also provided in-depth analytics and insights, through which the firm could track the effectiveness of their campaigns in real time. The result was a 200% increase in conversions within six months. In addition, the firm was able to achieve a 200% growth in earnings, a 300% rise in good leads, a 50% reduction in sales cycles, and overall higher engagement rates.
This could help an organization grow its customer base, revenue growth, and scale operations at the highest degree of efficiency. It automates outreach on LinkedIn, perfectly integrates with any CRM system, provides actionable insights and analytics, increases efficiency and productivity within their teams, and amplifies confidence in scaling their business.
In other words, Neebify is an efficient tool of a business that intends to automate lead generation, personal communication, organize smooth sales, and make decisions based on data to move fast. With Neebify, your business can be assured to be relevant in this high competition of the market for years to come.
1 note
·
View note
Text
Weekly Review December 6 2024
Some interesting links that I Tweeted about in the last week (I also post these on Mastodon, Threads, Newsmast, and Bluesky):
The majority of posts on LinkedIn are generated by AI: https://www.theregister.com/2024/11/28/linkedin_ai_posts/
Optical data transmission is the key to meeting the computing needs of AI: https://www.theregister.com/2024/11/28/ai_copper_cables_limits/
Possible legal obstacles to Google's AI plans: https://arstechnica.com/tech-policy/2024/11/google-drags-ai-rivals-into-search-trial-as-judge-entertains-ai-remedies/
Even though energy supplies are uncertain, investors continue to back building data centres to meet the computing needs of AI: https://www.theregister.com/2024/11/27/investor_datacenter_energy_concern/
An AI music generator that can produce sounds that have never existed before: https://arstechnica.com/ai/2024/11/nvidias-new-ai-audio-model-can-synthesize-sounds-that-have-never-existed/
Generative AI hallucinates and is unexplainable. How can organisations trust it? https://www.informationweek.com/machine-learning-ai/how-can-decision-makers-trust-hallucinating-ai-
What those responsible for IT security need to think about regarding AI regulations: https://www.informationweek.com/cyber-resilience/meeting-ai-regulations-a-guide-for-security-leaders
The academic and teaching benefits of having a conversation with an AI: https://www.insidehighered.com/opinion/career-advice/teaching/2024/11/27/how-ai-can-help-teach-art-conversation-opinion
Guardrails for health AI aim to reduce biased models: https://arstechnica.com/health/2024/11/biden-proposes-guardrails-on-health-care-ai-upping-weight-loss-drug-access/
Building your own AI app on a shoestring: https://www.kdnuggets.com/diy-ai-building-ai-apps-shoestring-budget
The British don't seem to be all that interested in AI: https://www.theregister.com/2024/11/29/ofcom_online_nation/
Britain is investing in AI to improve its cybersecurity: https://www.theregister.com/2024/11/26/uk_ai_security/
Some approaches to protect privacy when using AI: https://www.datasciencecentral.com/ethical-ai-in-data-practices-balancing-innovation-and-privacy/
Generative AI will hallcuinate citations rather than cite actual publications: https://techcrunch.com/2024/11/29/study-of-chatgpt-citations-makes-dismal-reading-for-publishers/
Yet another lawsuit from publishers over their material being used to train AI: https://techcrunch.com/2024/11/29/canadian-news-companies-sue-openai/
An overview of the last two years of ChatGPT and generative AI: https://www.computerworld.com/article/3615039/two-years-of-chatgpt-the-conversation-that-never-ends.html
The roles you need to fill for a successful AI project: https://www.bigdatawire.com/2024/11/26/building-your-genai-dream-team/
Building a successful AI strategy: https://www.bigdatawire.com/2024/11/19/tips-on-building-a-winning-data-and-ai-strategy-from-jpmc/
Cloning Panasonic's founder through AI: https://www.theregister.com/2024/11/29/panasonic_ai_founder/
AI can't make a bad photo good, to take good photos you need to be a good photographer: https://www.informationweek.com/machine-learning-ai/how-ai-is-revolutionizing-photography
How to assess when you should use generative AI: https://www.bigdatawire.com/2024/11/27/llms-and-genai-when-to-use-them/
AI that can detect a driver is dozing off: https://spectrum.ieee.org/driver-drowsiness-detection
Even AI needs a backup: https://arstechnica.com/tech-policy/2024/11/tech-problems-plague-openai-court-battles-judge-rejects-a-key-fair-use-defense/
Despite registering their use being mandatory, most British government users of AI are not doing so: https://www.theguardian.com/technology/2024/nov/28/uk-government-failing-to-list-use-of-ai-on-mandatory-register
0 notes
Text
Disney to Name Bob Iger’s Successor in 2026, Appoints James Gorman as New Chair

Source: telecom.economictimes.indiatimes.com
Share Post:
LinkedIn
Twitter
Facebook
Reddit
Walt Disney Company has officially set a timeline for the announcement of Bob Iger’s successor as CEO, signaling a critical milestone in its leadership transition. On Monday, Disney announced that the company would name Iger’s replacement in early 2026, marking the first time the entertainment giant has set a formal timetable for this crucial decision.
The move is seen as a long-awaited step toward addressing Disney’s succession challenges, which have plagued the company for several years. Iger, known for transforming Disney through key acquisitions, including Pixar, Marvel, and Lucasfilm, has had his retirement date extended multiple times. Initially returning from retirement in 2022 after his chosen successor, Bob Chapek, was ousted, Iger had planned to stay for two years but later extended his tenure until 2026.
While the announcement comes as a relief to many investors, the search for a suitable successor to Bob Iger remains a critical challenge. Disney has yet to make a final decision, with several internal and external candidates in the running for the role. The succession plan will be closely monitored as Disney aims to ensure a smooth leadership transition before Iger’s expected departure.
James Gorman to Lead Disney’s Board as Chair
In addition to revealing the CEO succession timeline, Disney also announced the appointment of James Gorman, a veteran executive from Morgan Stanley, as its new chairman of the board. Gorman, who will take over the role on January 2, 2024, brings a wealth of experience, having served as CEO of Morgan Stanley for 14 years, where he led the firm through significant growth, particularly in its wealth management division.
Gorman’s leadership in executing Morgan Stanley’s own succession plan, which saw Ted Pick assume the CEO role while other contenders remained at the firm, has earned him praise from peers. His focus on transparency and rigor in leadership transitions is expected to play a key role as Disney embarks on its search fo rBob Iger’s replacement.
The appointment of Gorman comes as Mark Parker, the current chair of Disney and executive chairman of Nike, steps down after nine years on Disney’s board. Parker expressed confidence in Gorman’s leadership, noting that his experience would be instrumental in guiding Disney through its CEO succession process, a top priority for the board.
Candidates for Disney’s CEO Role Emerge
As Disney gears up for the 2026 leadership transition, several internal candidates are emerging as potential successors to Bob Iger. Among the contenders is Dana Walden, Disney Entertainment Co-Chair, who is seen as a creative executive with a track record of success in television. Walden’s deep relationships with talent and her creative vision align closely with Bob Iger’s leadership style, making her a strong candidate.
Other potential successors include Josh D’Amaro, the charismatic chairman of Disney Experiences, who oversees the company’s lucrative theme park operations, and Jimmy Pitaro, the chairman of ESPN, known for spearheading the sports network’s digital transformation. Alan Bergman, a Disney veteran who oversees the company’s film studios, is also seen as a strong contender, having led successful box office hits this year.
Disney’s board, led by Gorman, will continue to evaluate both internal and external candidates as the company prepares for its leadership transition. As the process unfolds, investors and analysts will keep a close watch on the company’s efforts to ensure a smooth and successful handover in 2026.
#Disney#BobIger#CEOSuccession#JamesGorman#LeadershipTransition#EntertainmentIndustry#DisneyNews#BusinessLeadership#Investors#FutureOfDisney
0 notes
Text
Tech Recruitment Terrain: Where Are the Talents Hidden?

In today’s fast-evolving digital landscape, finding the right talent for tech roles is like searching for gold in a crowded mine. With technology reshaping industries at an unprecedented pace, companies rely heavily on tech recruitment agency to meet their hiring needs. These agencies, like Huntly, are not merely intermediaries but strategic partners helping organizations navigate the intricate web of tech talent acquisition. But how exactly do these agencies operate, and why have they become indispensable in the modern hiring ecosystem? This article delves into the hidden terrain of tech recruitment, the challenges involved, and why tech companies increasingly lean on specialized recruitment agencies to uncover the industry's hidden talent gems. The Changing Landscape of Tech Recruitment The tech sector is unlike any other. The speed of innovation and the demand for specialized skills have made traditional hiring practices largely ineffective for many companies. The needs of tech firms are not static; they are dynamic, changing in tandem with new technologies, programming languages, and industry trends. This is where tech recruitment agencies like Huntly make their mark. These agencies understand the dual importance of technical proficiency and cultural compatibility. It’s not just about filling open positions—it's about ensuring long-term success by placing the right people in the right environment. These agencies build relationships with employers and candidates, providing a match that benefits all parties. But what does tech recruitment look like today, and where are the talents hiding? Challenges in Tech Talent Acquisition Tech talent acquisition is far more nuanced than other industries. Tech firms are not just looking for employees to fill a role; they need problem solvers, innovators, and individuals who can work within fast-paced, collaborative environments. Here are some of the unique challenges faced in this space: - Skills Gap - A significant skills gap plagues the tech industry. Emerging technologies like AI, machine learning, blockchain, and cloud computing require expertise that’s often hard to find. While many candidates have the potential to learn, companies frequently need talent that can hit the ground running. Tech recruitment agencies specialize in identifying and nurturing such talent, often bridging this gap by sourcing candidates with the proper education, experience, and adaptability mix. - Speed of Innovation - In tech, change happens fast. New programming languages, tools, and frameworks emerge regularly. As a result, companies need to recruit individuals proficient in existing technologies and quick learners who can adapt to new trends. Traditional HR departments may not have the capacity or expertise to keep up with these changes, but recruitment agencies focusing on tech know precisely what to look for. - Passive Candidates - Most top tech talent is not actively seeking new roles. These passive candidates are often happily employed but open to exciting new opportunities. Tech recruitment agencies have the networks and relationships to tap into this hidden talent pool. They understand how to attract these individuals, often positioning roles as growth opportunities rather than just job changes. A Day in the Life of a Tech Recruitment Agency The daily operations of a tech recruitment agency are a blend of art and science. A successful agency must balance understanding the intricate technical needs of a role with the softer skills of networking and relationship-building. Here's a glimpse of what goes on behind the scenes: - Sourcing Talent - Sourcing is one of the most critical tasks for a tech recruitment agency. They don’t rely on job boards and LinkedIn; they tap into niche communities, attend industry events, and leverage referrals. The goal is to find candidates whose skills align with the technical aspects of a job and the company's culture. - Analyzing Resumes - The tech world is rife with jargon, acronyms, and niche skills that can be hard for traditional HR professionals to navigate. Tech recruiters, however, are well-versed in these terms and can quickly identify candidates with the proper skill set. But it’s not just about technical expertise—recruiters assess soft skills, adaptability, and a candidate's fit within the company culture. - Building Relationships - Networking is vital in tech recruitment. The best talent often isn’t actively seeking a job, so building and maintaining relationships is crucial. Agencies spend time nurturing relationships with potential candidates, keeping them engaged even when there isn’t an immediate role for them. This allows agencies to move quickly when the right opportunity comes along. - Keeping Up with Trends - A good tech recruiter needs to be as tech-savvy as the candidates they recruit. Staying updated on the latest trends, emerging technologies, and market demands allows recruitment agencies to remain competitive and offer their clients the best candidates. This continuous learning also gives them insights into the evolving needs of the companies they work with, helping them anticipate future hiring challenges. Why Tech Companies Lean on Recruitment Agencies Securing premium talent can make or break a company's success in the competitive tech world. This is why many tech firms turn to recruitment agencies for assistance. But what are the key reasons these agencies have become vital to the tech hiring process? - Access to Premium Talent - Recruitment agencies often have access to top-tier talent that traditional hiring methods can’t reach. Their deep networks include passive candidates, tech influencers, and even talent from competitor companies. This direct line to premium talent can accelerate a company’s growth and innovation. - Cultural Fit - One common misconception is that hiring for tech roles is solely about technical skills. In reality, cultural fit is just as crucial. Employees who align with a company’s culture are more likely to thrive and contribute to its long-term success. Recruitment agencies excel in this area, identifying candidates with the technical skills and sharing the company’s values and work style. - Time and Cost Efficiency - Hiring can be time-consuming and expensive, especially for niche tech roles. By outsourcing this function to specialized agencies, tech companies can save time and money. Agencies streamline the process by handling everything from sourcing to vetting, allowing the company to focus on growth and innovation rather than recruitment logistics. The Future of Tech Recruitment As technology continues to evolve, so will the tech recruitment field. Agencies in this sector are continuously adapting to new trends, technologies, and hiring needs. This agility is not just beneficial—it’s essential for staying competitive. - AI and Automation - Integrating AI and automation in recruitment is already transforming how agencies operate. AI-driven applicant tracking systems (ATS) can now sift through hundreds of resumes in a fraction of the time it would take a human. These systems use algorithms to match candidates with roles, reducing bias and improving the efficiency of the hiring process. - Predictive Analytics - Agencies are beginning to leverage predictive analytics to anticipate hiring needs and trends. By analyzing data from previous hires, market trends, and company growth, recruitment agencies can help companies prepare for future talent needs before they arise. - Remote Hiring - The rise of remote work has expanded the talent pool for tech companies. Recruitment agencies are now sourcing talent from across the globe, ensuring that companies can access the best professionals, regardless of location. This trend is expected to continue, with remote hiring becoming a staple of tech recruitment. Conclusion In summary, tech recruitment agencies are far more than simple mediators in the hiring process. They are strategic partners, deeply embedded in the tech world, helping companies navigate the complexities of finding and securing top talent. By combining technical expertise, networking prowess, and an understanding of company culture, these agencies play a crucial role in shaping the teams that drive innovation in the tech industry. As the work landscape continues to evolve, the importance of tech recruitment agencies will only grow, making them indispensable players in the workforce of tomorrow. Read the full article
0 notes